Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement
about
The purification and properties of the second component of guinea-pig complementControl of the amplification convertase of complement by the plasma protein beta1HThe internal thioester and the covalent binding properties of the complement proteins C3 and C4Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivatorThe human complement system: assembly of the classical pathway C3 convertaseCleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4bAlternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathwayComplement system in synovial fluids from patients with rheumatoid arthritis.Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.Genetic polymorphism of the third component of human complement (C'3).In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemiaStructural polymorphism of the fourth component of human complementFunctional analyses of complement convertases using C3 and C5-depleted sera.Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3BActivation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.Properdin: initiation of alternative complement pathway.C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.Complement metabolism in man: hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary, angioedema (HAE).Effect of rheumatoid factor on complement-mediated phagocytosis.A molecular concept of the properdin pathway.Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement componentsFluid phase destruction of C2hu by C1hu. I. Its enhancement and inhibition by homologous and heterologous C4.Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum.The antigenic and molecular alterations of C3 in the fluid phase during an immune reaction in normal human serum. Demonstration of a new conversion product, C3xProperdin factor D. II. Activation to D by properdin.Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodiesRequirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.Purificaiton and characterization of mouse serum protein with specific binding affinity for C4 (Ss protein)Activation of the classical pathway of complement by Hageman factor fragment.Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.Multiple sedimenting species of properdin in human serum and interaction of purified properdin with the third component of complementComplement activation, regulation, and molecular basis for complement-related diseasesEvidence for presence of an internal thiolester bond in third component of human complement.Antibody-dependent alternate pathway of complement activation in opsonophagocytosis of Porphyromonas gingivalis.Nephritic factor of the classical pathway of complement: immunoglobulin G autoantibody directed against the classical pathway C3 convetase enzymeReduction by cobra venom factor of myocardial necrosis after coronary artery occlusion.
P2860
Q24530130-7539F235-8EA4-4D30-B475-DEB9360DFE64Q24561671-ED851860-0C58-4F48-815B-02CB41F904FBQ28304143-23297C9E-DF85-4A27-B167-0EAD007DE8B8Q28610968-F046893E-2693-4630-89F4-9992B25C64A2Q28610994-8E8849AB-2735-4FAA-84DF-DAF5377430F4Q28610999-8CFE8C2F-BC53-4F95-B1AA-109E0524463EQ28611040-6D5F0152-1079-4799-A269-18CD5D75A5F2Q33580015-66F42538-162D-4A14-A095-3ADDAF2A0B8FQ34089408-F0C1B1D6-1132-4A47-885C-BF548D0E7E0CQ34278770-F8B8B11F-E3DF-4F1B-AF19-8F6FE5AD37FCQ34280252-6AB14ABB-E8FA-426E-88A7-1BA78BFA6D21Q34283625-18ABB292-32CB-4FB6-83CD-8BFF57D8A7F4Q34448109-D4271680-52E7-4095-97EE-44390DDC67FEQ34475397-063F7269-F4D5-484C-AB4C-E53DD76B81E1Q35020107-C9F0B1B6-76B1-4323-A6E3-E702E01D2D91Q35086636-EF17A9CC-D204-46CB-9291-2B3B4A59CC91Q35201919-2DDDF890-776F-485E-B0C7-34918C4DCEE7Q35572234-85C3CFED-1997-4817-91E3-DA6FD165F1B4Q35898277-A58EAAA5-6A05-4B08-9AAF-AB2359C420B3Q35986109-1917249F-C113-4ECC-955E-5A45A34DC79BQ36268929-96910D18-D046-48B3-A45E-1D38EC1BDA16Q36268987-3FBBBFFE-E0BE-44F3-BC5E-88394A1B1654Q36269413-1AC74C32-2FDC-4B6F-88D9-DECA54C93CC3Q36269627-DB4F33FF-8EE9-484B-A649-55AEB3D18AE3Q36269678-2DC82392-7543-4933-9AF7-B0C9BBB006E3Q36269730-B7CB5A54-6DC0-4415-B548-2699B6518BDBQ36270397-ED80C5E6-5F5F-45ED-8465-D52F0672B2AFQ36271257-41F703C9-CDC6-4C81-9795-4006047FEFBDQ36273129-C56265A8-5C6B-45BA-B56F-9A36ED4850D1Q36296755-DA97639D-F1A1-46E0-85BE-D3EC61B83E33Q36335075-D6E34A55-C2A3-4A11-B8C1-539726BFACE4Q36335959-D5A602B0-0D1A-4560-BE9F-D1206F56CFDDQ36344568-E4A3714C-A56D-4234-9EEC-B5F13103AFE8Q36345338-327EE079-6BE7-4BA4-A003-6AF47E3763F6Q36359041-C4803670-703E-4191-ABEF-9E7AB345239AQ36380682-1E1F69BA-334F-4D76-90F0-8405646D17D6Q36409419-15E85396-2A71-489B-908F-2F3627E0A909Q36965172-722D7183-F33B-4C22-9C29-F56F3C186B2AQ37022991-48A689ED-1E40-4B87-B45F-3058D70C7C86Q37051852-AEDF760D-B788-4F4D-9C8D-4C021DC1D20A
P2860
Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement
description
1967 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1967 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1967
@ast
im Februar 1967 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1967/02/01)
@sk
vědecký článek publikovaný v roce 1967
@cs
wetenschappelijk artikel (gepubliceerd op 1967/02/01)
@nl
наукова стаття, опублікована в лютому 1967
@uk
مقالة علمية (نشرت في فبراير 1967)
@ar
name
Formation and functional signi ...... component of human complement
@ast
Formation and functional signi ...... component of human complement
@en
Formation and functional signi ...... component of human complement
@nl
type
label
Formation and functional signi ...... component of human complement
@ast
Formation and functional signi ...... component of human complement
@en
Formation and functional signi ...... component of human complement
@nl
prefLabel
Formation and functional signi ...... component of human complement
@ast
Formation and functional signi ...... component of human complement
@en
Formation and functional signi ...... component of human complement
@nl
P2093
P2860
P356
P1476
Formation and functional signi ...... component of human complement
@en
P2093
H. J. Müller-Eberhard
M. A. Calcott
M. J. Polley
P2860
P304
P356
10.1084/JEM.125.2.359
P407
P577
1967-02-01T00:00:00Z